anmelden
GSK Aktie
21,72
EUR
-0,07
EUR
-0,32
%
21,69
EUR
+0,18
EUR
+0,84
%
GSK jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 85,2 Mrd. EUR
KGV 12,93 Div. Rendite 3,62%WKN A3DMB5
ISIN GB00BN7SWP63
Symbol GLAXF
AI Analyse
Werbung
GSK Aktie Analyse
| 23.07.08 | GSK hold | Société Générale Group S.A. (SG) | |
| 25.06.08 | GSK hold | ROTH Capital Partners, LLC | |
| 23.04.08 | GSK hold | Société Générale Group S.A. (SG) | |
| 18.02.08 | GSK neutral | JP Morgan Chase & Co. | |
| 08.02.08 | GSK hold | Société Générale Group (SG) | |
| 22.01.08 | GSK neutral | JP Morgan Chase & Co. | |
| 16.08.07 | GSK neutral | JP Morgan Chase & Co. | |
| 13.06.07 | GSK hold | Société Générale (SG) | |
|
Werbung
|
|||
| 30.05.07 | GSK hold | HypoVereinsbank | |
| 25.05.07 | GSK neutral | Banc of America Sec. | |
| 25.05.07 | GSK hold | Société Générale (SG) | |
| 23.05.07 | GSK hold | Deutsche Securities | |
| 03.04.07 | GSK neutral | UBS | |
| 18.01.07 | GSK hold | Roth Capital | |
| 18.01.07 | GSK Hold | Roth Capital | |
| 05.12.06 | GSK equal-weight | Morgan Stanley | |
| 10.11.06 | GSK halten | Helaba Trust | |
| 02.11.06 | GSK neutral | JP Morgan | |
| 01.11.06 | GSK equal-weight | Morgan Stanley | |
| 04.08.06 | GSK neutral | Goldman Sachs | |
| 28.07.06 | GSK halten | Helaba Trust | |
| 25.07.06 | GSK neutral | Cowen & Co | |
| 11.05.06 | GSK in-line | Goldman Sachs | |
| 04.04.06 | GSK neutral | UBS | |
| 04.04.06 | GSK Neutral | UBS | |
| 04.04.06 | GSK Neutral | UBS | |
| 29.03.06 | GSK hold | Deutsche Securities | |
| 29.03.06 | GSK equal-weight | Morgan Stanley | |
| 03.03.06 | GSK equal-weight | Morgan Stanley | |
| 23.02.06 | GSK equal-weight | Morgan Stanley | |
| 13.02.06 | GSK in-line | Goldman Sachs | |
| 09.02.06 | GSK halten | Helaba Trust | |
| 06.02.06 | GSK Underweight | Prudential Securities | |
| 19.01.06 | GSK halten | Helaba Trust | |
| 25.11.05 | GSK in-line | Goldman Sachs | |
| 21.11.05 | GSK Neutral | Credit Suisse First Boston | |
| 21.11.05 | GSK halten | Helaba Trust | |
| 21.11.05 | GSK in-line | Goldman Sachs | |
| 21.11.05 | GSK neutral | Credit Suisse First Boston | |
| 21.11.05 | GSK equal-weight | Morgan Stanley | |
| 03.11.05 | GSK peer perform | Bear Stearns | |
| 03.11.05 | GSK Peer Perform | Bear Stearns | |
| 28.10.05 | GSK halten | Helaba Trust | |
| 12.09.05 | GSK equal-weight | Morgan Stanley | |
| 26.08.05 | GSK halten | Helaba Trust | |
| 18.08.05 | GSK Neutral | JP Morgan | |
| 29.07.05 | GSK halten | Helaba Trust | |
| 25.07.05 | GSK halten | Helaba Trust | |
| 18.07.05 | GSK market perform | Leerink Swann | |
| 15.07.05 | GSK Market Peform | Leerink Swann | |
Werbung
Werbung
